Mesa Labs SVP sells 1,151 company shares
Mesa Laboratories senior vice president of operations Brian David Archbold reported an open-market sale of company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Mesa Laboratories senior vice president of operations Brian David Archbold reported an open-market sale of company stock. On June 16, 2026, he sold 1,151 shares of Mesa Laboratories common stock at an average price of $101.267 per share. After this transaction, he continues to hold 3,710 shares directly.
Insider Trade Summary 10b5-1
Net Seller: 1,151 shares
Net Sell
1 txn
Insider
Archbold Brian David
Role
SVP Operations
Sold
1,151 shs ($117K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,151 | $101.267 | $117K |
Holdings After Transaction:
Common Stock — 3,710 shares (Direct)
Key Figures
Shares sold: 1,151 shares
Sale price: $101.267 per share
Shares remaining: 3,710 shares
+1 more
4 metrics
Shares sold
1,151 shares
Common Stock sold on June 16, 2026
Sale price
$101.267 per share
Average price for the open-market sale
Shares remaining
3,710 shares
Total common shares directly owned after transaction
Net shares sold
1,151 shares
Net-sell direction in transaction summary
Key Terms
open-market sale, Common Stock, Form 4, net-sell
4 terms
open-market sale financial
"transaction_action: "open-market sale" for 1,151 shares of Common Stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
"security_title: "Common Stock" with 1,151 shares sold at $101.267"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 financial
"Mesa Laboratories insider transaction was disclosed on a Form 4 filing"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
net-sell financial
"transactionSummary shows netBuySellDirection as "net-sell" for the period"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Mesa Laboratories (MLAB) report for Brian David Archbold?
Mesa Laboratories reported that SVP Operations Brian David Archbold sold 1,151 shares of common stock. The open-market sale occurred at an average price of $101.267 per share and was disclosed on a Form 4 insider trading report.
What was the sale price in the Mesa Laboratories (MLAB) insider transaction?
The reported Mesa Laboratories insider transaction was executed at an average price of $101.267 per share. This price applies to the 1,151 common shares sold by senior vice president of operations Brian David Archbold in an open-market sale reported on Form 4.
What does the Form 4 filing reveal about Mesa Laboratories (MLAB) insider trading direction?
The Form 4 filing shows a net-sell direction for Mesa Laboratories. Brian David Archbold completed one open-market sale of 1,151 common shares and no purchases, resulting in net selling activity for this reporting period according to the transaction summary.
Is the Mesa Laboratories (MLAB) insider transaction a direct or indirect holding change?
The Mesa Laboratories insider transaction reflects a change in direct holdings. The Form 4 classifies the 1,151 shares sold by Brian David Archbold as directly owned, and it reports that he continues to directly own 3,710 common shares after the sale.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates